A fast and easy way to find out about all new FDA approved cancer treatments.
Thursday, February 28, 2013
Stivarga approved for GIST
Stivarga (regorafenib) has been approved for the treatment of GIST (GI stromal tumors) in patients with unresectable disease who have failed other treatments.
No comments:
Post a Comment